| Author (Corporate) | European Court of Justice: Press and Information Division |
|---|---|
| Series Title | Press Release |
| Series Details | No. 112, 2011 (18.10.11) |
| Publication Date | 18/10/2011 |
| Content Type | News |
|
A process which involves removal of a stem cell from a human embryo at the blastocyst stage, entailing the destruction of that embryo, cannot be patented. The use of human embryos for therapeutic or diagnostic purposes which are applied to the human embryo and are useful to it is patentable, but their use for purposes of scientific research is not patentable. |
|
| Source Link | Link to Main Source http://curia.europa.eu/jcms/upload/docs/application/pdf/2011-10/cp110112en.pdf |
| Subject Categories | Internal Markets, Law |
| Countries / Regions | Europe, Germany |
